Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
84
CIMA_AEMPS:81
NMPA:2
PHILIPPINES:1
Drug Approvals
Riluzole Oral Suspension
- Product Name
- 利鲁唑口服混悬液
- Approval Number
- 国药准字HJ20220053
- Approval Date
- May 31, 2022
NMPA
Iron Proteinsuccinylate Oral Solution
- Product Name
- 菲普利
- Approval Number
- 国药准字HJ20160143
- Approval Date
- Feb 10, 2021
NMPA
Clinical Trials
No trials found
News
No news found